Zai Lab Announces Participation in Investor Conferences in November and December 2025
SHANGHAI & CAMBRIDGE, Mass.–(BUSINESS WIRE)–
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following investor conferences in November and December 2025:
Jefferies Global Healthcare Conference in London
Fireside Chat: Wednesday, November 19, 2025 at 8:30AM GMT
Location: London
Citi’s 2025 Global Healthcare Conference
Fireside Chat: Tuesday, December 2, 2025 at 1:00PM ET
Location: Miami, Florida
Live webcasts will be available on the Investor Relations page of Zai Lab’s website at ir.zailaboratory.com/webcasts-presentations and archived replays will be available for up to 90 days following the completion of the events.
About Zai Lab
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing innovative products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. Our goal is to leverage our competencies and resources to positively impact human health.
For additional information about Zai Lab, please visit www.zailaboratory.com or follow us at www.X.com/ZaiLab_Global.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251031556994/en/
For more information, please contact:
Investor Relations:
Christine Chiou / Cyan Liu
+1 (917) 886-6929 / +86 195 3130 8895
[email protected] / [email protected]
Media:
Shaun Maccoun / Xiaoyu Chen
+1 (857) 270-8854 / +86 185 0015 5011
[email protected] / [email protected]
KEYWORDS: China United States North America Asia Pacific Massachusetts
INDUSTRY KEYWORDS: Biotechnology Health General Health Pharmaceutical Oncology Neurology Health Technology Research Infectious Diseases Science Clinical Trials
MEDIA:
| Logo |
 |